Kevin Sheth, MD, discusses the role of computed tomography perfusion amid stroke diagnosis.
This is a video synopsis/summary of a Post Conference Perspectives involving Kevin Sheth, MD.
This is a video discussing the role of CT perfusion in the management of ischemic stroke patients, specifically focusing on an abstract presented regarding mechanical thrombectomy in ischemic stroke patients without salvageable brain tissue based on CT perfusion imaging.
Sheth explains that at Yale, CT perfusion is part of the routine clinical evaluation of acute stroke patients. It provides quantitative assessment of the infarct core and penumbral tissue to verify stroke diagnosis, characterize stroke severity, assist in family discussions, and guide potential interventions.
The methods of the discussed observational study involved evaluating multimodal CT scans, including CT perfusion, in ischemic stroke patients to develop mismatch profiles quantifying infarct core and penumbral tissue. These were related to details of endovascular treatment and functional independence at 90 days. Statistical adjustments were made for baseline differences.
Key findings were an interaction between recanalization status, age, and infarct extent, suggesting mechanical thrombectomy may be most effective in patients under 70 years old with moderate infarct volumes. Propensity score matching analyses in subgroups showed similar functional independence rates between patients.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe
April 1st 2025These are data to week 26 on the monoclonal antibody and antineoplastic agent; data out to week 52 of the MINT trial will be presented in a late-breaking oral session at the upcoming American Academy of Neurology Annual Meeting.
Read More
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
March 26th 2025With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
Read More
PAH Therapies Improve Outcomes in PH-ILD
March 26th 2025Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among individuals who have idiopathic pulmonary fibrosis. Overall, most cases of PH in the setting of ILD are mild.
Read More